FDA Investigator Frederick Razzaghi

Frederick Razzaghi has inspections in 13 countries as of 27 Oct 2023. Frederick Razzaghi has collaborated with a combinined 5739 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
150
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100001999
Country:
United States of America, France, Switzerland, United Kingdom of Great Britain and Northern Ireland, Hungary, Canada, Denmark, India, Germany, Ireland, Brazil, Bulgaria, Sweden
Co-Investigator(s):
Addam S Reynolds, Adetutu M Gidado, Akbar J Zaidi, Alberto A Viciedo, Alice S Tsao, Alicia M Mozzachio, Amy L Singer, Amy M Codella, Amy M Cramer, Angela E Glenn, Ankur C Patel, Ann Marie Montemurro, Anna Lazar, Anna M Brannen, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony C Warchut, Anthony J Donato, Arsen Karapetyan, Ashley J Burns, Ashutosh Rao, PhD, Atul J Agrawal, Audrey Thereset Uy, Azza Talaat, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara M Frazier, Bei Yu, Brandon C Heitmeier, Brandy N Lepage, Bryan L Mcguckin, Byungja E Marciante, Carl A Huffman, III, Cassandra L Abellard, Catherine J Laufmann, Charles I Ann, Charles J Chacko, Cheryl A Clausen, Chiang Syin, PhD, Christina A Miller, Christina K Theodorou, Christina P Burkhart, Courtney N Long, Craig D Zagata, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Dale A Nyberg, Dan Grabicki, Daniel J Grabicki, Daniel J Min, Daniel L Zheng, Darren S Brown, David A Oluwo, David E Bailey, David M Beltran, David S Jackson, Dawn L Wydner, Deborah B Nixon, Debra I Love, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Dhaval H Patel, Donald C Obenhuber, PhD, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward Oshaughnessy, Elaine E Gilfillan, Elizabeth M Jacobson, Emest Bizjak, Emest F Bizjak, Emmanuel J Ramos, Eric M Mueller, PharmD, Eric Rothschild, Erik W Koester, Erin D Mccaffery, Ernest F Bizjack, Ernie F Bizkaj, Esteban Beltran, Eufemia G Gonzalez, Evelyn Taha, Ferderick Razzaghi, Francis A Guidry, Frank J Marciniak, Fred Razzaghi, Frederick Razzack, Geraldine D Sanders, Gianine E Tompkins, Gobiga Vanniyasingam, Graeme E Price, Guerlain Ulysse, Gwyn G Dickinson, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Ivis Lnegron Torres, Jacob G Lutz, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, James Norman, James P Mcreavey, James R Birkenstamm, Janet A Rajan, Jason F Chancey, Jason M Sluzynski, Jay B Shah, Jay T Wong, Jean Blackston Hill, Jean Blackstone Hill, Jean M Mulinde, MD, Jeffrey A Sommers, Jeffrey J Ebersole, Jennifer C Adams, Jennifer Macmillan, Jessica M Monteiro, Jessica S Estriplet, Joanne E King, Jogy George, Jonathan G Matrisciano, Jonathan S Helfgott, Jonee J Mearns, Joohi Castelvetere, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Cayuela, Jose O Hernandez, Joseph Duca, Josh Renzon Ramilo, Jot R Klena, Joy R Kozlowski, Joy Rkozlowski Klena, Juanita P Versace, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Karishma Gopaul, Kathleen R Jones, PhD, Keith M Reilly, Kelli F Dobilas, Kenneth M Gordon, Kent C Faul, Kevin P Foley, Kham Phommachanh, King, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Kristy E Zuroski, Krystal O Ogunremi, Kwong P Lee, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Lawrence Harmon, Jr, LCDR Debra Emerson, Lcr Jayt Wong, Li Li, Liatte Kreuger, PharmD, Lily Y Koo, Linda M Cheny, Lisa L Flores, Lisa M Bellows, Lisa M Feola, Loretta Nemchik, Luis A Dasta, Lydia Irosas Marty, Marcelo O Mangalindan, Jr, Marcia Gelber, Marcus F Yambot, Marea K Harmon, Margaret M Sands, Margaret Sand, Maria A Bienkowski, Maria A Reed, Maria Estrella, Maria Estrella Jimenez, Marie A Fadden, Marie Bbuen Bigornia, Mark R Mcclain, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael Gurbarg, Michael L Casner, Michael R Goga, Michael R Klapal, Michael Serrano, Michele Perry Williams, Michelle M Parisi, Mikhail V Ovanesov, PhD, Monica E Murie, Monica M Mcclure, Monika Borkowska, Morea K Harmen, Mra Davism, Muralidhara B Gavini, PhD, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Naveen B Kanthamneni, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Nicola M Fenty Stewart, Niketa Patel, Nikki S Ramirez, Nina Yang, Nyungja E Marciente, Odera I Ekwunife, Pal S Mayasandra, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paul Mouris, Paula A Trost, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Pushpa S Jayasekara, Rajiv R Srivastava, Ramon E Martinez, Randy L Self, Raymond L Cheung, Raymond T Oji, Regina T Brown, Richard E Needham, Richard H Penta, Richard J Muzeni, Robert C Steyert, Robin P Mathew, Rochelle L Cross, Roger F Zabinski, Rose Ljean Mary, Rose Xu, Russell J Glapion, Saleem A Akhtar, Samantha J Bradley, Samir C Gala, Samuel T Walker, Sandra A Hughes, Sandra Kershaw, Sangeeta M Khurana, PhD, Sarah Adella Fave, Sarah E Mcmullen, Sarah Forney, Satheesh K Podaralla, Satheesh Thomas, Sayyem H Akbar, Schultz, Sean G Casey, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shelby N Marler, Sherri J Liu, Shirley S Wen, Simone E Pitts, Sinai Davis, Sneha S Patel, Sony Mathews, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen D Eich, Stephen J Koniers, Stephen J Mottola, Steven M Weinman, Susan M Halsted, Susan M Jackson, Susant Hadman, Syeda N Mahazabin, Taichun Qin, PhD, Tamara Brey, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Thomas J Arista, Tiffani D Wilson, Timothy T Kapsala, Tina M Pawlowski, Tonia F Bernard, Toyin B Oladimeji, Tricia S Martinez, Truong Xuan Nguyen (Andy), Unnee Ranjan, Valerie C Reed, Victoria Spivak, Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Wayne J Meyer, William Chang, William J Leonard, William J Muszynski, William R Chang, Xiaokuang Lai, PhD, Yasamin Ameri, Ying Zhang, Yong Wu, PhD, Youmin Wang, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Yvonne E Lozano, Zhaohui Ye

Frederick Razzaghi's Documents

Publish Date Document Type Title
February, 2011 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2011-02-17
August, 2010 EIR Biovail Technologies, Ltd - EIR, 2010-08-27
February, 2012 FDA 483 davAgen Pharmaceutical, LLC - Form 483, 2012-02-27
March, 2012 EIR BASF Corporation - EIR, 2012-03-30
August, 2011 FDA 483 Renaissance Lakewood LLC - Form 483, 2011-08-10
March, 2015 EIR Quantum Analytics Group Inc. - EIR, 2015-03-19
October, 2022 FDA 483 Cyalume Specialty Products - Form 483, 2022-10-03
April, 2016 EIR RARITAN PHARMACEUTICALS INCORPORATED - EIR, 2016-04-14
February, 2010 FDA 483 Vertical Pharmaceuticals, LLC - Form 483, 2010-02-24
December, 2013 FDA 483 AustarPharma, LLC - Form 483, 2013-12-18
February, 2020 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2020-02-28
April, 2015 EIR Curia New Jersey, LLC - EIR, 2015-04-06
January, 2017 FDA 483 Primera Analytical Solutions Corporation - Form 483, 2017-01-23
June, 2012 FDA 483 Guardian Drug Company - Form 483, 2012-06-08
June, 2012 FDA 483 New Jersey Laboratories - Form 483, 2012-06-29
May, 2012 FDA 483 Davion, Inc - Form 483, 2012-05-10
February, 2015 EIR Excellentia International, LLC - EIR, 2015-02-27
February, 2015 FDA 483 Excellentia International, LLC - Form 483, 2015-02-27
April, 2018 FDA 483 Patheon Biologics (NJ) LLC - Form 483, 2018-04-09
March, 2014 FDA 483 ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483, 2014-03-05
December, 2014 FDA 483 BASF Corporation - Form 483, 2014-12-04
February, 2018 FDA 483 Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - Form 483, 2018-02-06
November, 2013 EIR Cosette Pharmaceuticals, Inc. - EIR, 2013-11-19
February, 2015 FDA 483 Renaissance Lakewood LLC - Form 483, 2015-02-06
August, 2013 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2013-08-20
September, 2017 EIR Merck Kommanditgesellschaft auf Aktien - EIR, 2017-09-08
December, 2014 FDA 483 Response BASF Corporation - Form 483R, 2014-12-16
June, 2010 FDA 483 Sonar Products, Inc. - Form 483, 2010-06-21
January, 2017 EIR Primera Analytical Solutions Corporation - EIR, 2017-01-23
April, 2010 FDA 483 Colgate-Palmolive Company - Form 483, 2010-04-30
July, 2015 EIR APNAR PHARMA LLP - EIR, 2015-07-10
April, 2019 FDA 483 Perritt Laboratories, Inc - Form 483, 2019-04-19
December, 2014 FDA 483 Cosmax USA, Inc. (Cosmax USA, Corporation) - Form 483, 2014-12-22
March, 2013 FDA 483 A.P. Deauville, LLC - Form 483, 2013-03-04
June, 2017 FDA 483 Bentley Laboratories, LLC - Form 483, 2017-06-09
March, 2012 FDA 483 BASF Corporation - Form 483, 2012-03-30
December, 2011 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2011-12-02
October, 2019 FDA 483 Aurolife Pharma LLC - Form 483, 2019-10-22
May, 2018 FDA 483 CMIC CMO USA CORP - Form 483, 2018-05-08
September, 2021 FDA 483 Premier Trends LLC - Form 483, 2021-09-29
September, 2014 FDA 483 Bentley Laboratories, LLC - Form 483, 2014-09-02
October, 2011 FDA 483 Allcare Medical - Form 483, 2011-10-12
August, 2013 EIR Vantage Specialty Ingredients, Inc - EIR, 2013-08-20
March, 2015 FDA 483 Response Quantum Analytics Group Inc. - Form 483R, 2015-04-03
April, 2016 FDA 483 RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2016-04-14
March, 2018 FDA 483 AptaPharma Inc. - Form 483, 2018-03-16
May, 2015 FDA 483 Liberty Drug & Surgical - Form 483, 2015-05-22
August, 2012 FDA 483 Suite K Value Added Services LLC - Form 483, 2012-08-20
April, 2013 EIR Alcami Corporation - EIR, 2013-04-09
April, 2017 FDA 483 Scientech Laboratories, Inc. - Form 483, 2017-04-25
August, 2015 FDA 483 Celgene Corporation - Form 483, 2015-08-04
September, 2018 FDA 483 Curexa - East, LLC dba Curexa - Form 483, 2018-09-27
May, 2014 FDA 483 Shiseido America Inc. - Form 483, 2014-05-12
April, 2013 FDA 483 Alcami Corporation - Form 483, 2013-04-09
March, 2015 FDA 483 Quantum Analytics Group Inc. - Form 483, 2015-03-19
February, 2015 EIR Renaissance Lakewood LLC - EIR, 2015-02-06
March, 2010 FDA 483 Viant Medical, Inc. - Form 483, 2010-03-03
April, 2017 EIR New Jersey Laboratories - EIR, 2017-04-12
June, 2017 EIR Bentley Laboratories, LLC - EIR, 2017-06-09
February, 2018 FDA 483 Response Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - Form 483R, 2018-04-01
June, 2021 FDA 483 MSN Pharmaceuticals Inc. - Form 483, 2021-06-16
June, 2016 EIR Appco Pharma LLC - EIR, 2016-06-27
September, 2020 FDA 483 Carnegie Pharmaceuticals, LLC - Form 483, 2020-09-03
June, 2018 FDA 483 Aurolife Pharma LLC - Form 483, 2018-06-14
March, 2018 EIR AptaPharma Inc. - EIR, 2018-03-29
February, 2019 EIR Novitium Pharma LLC - EIR, 2019-02-04
December, 2011 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2011-12-02
February, 2019 FDA 483 Novitium Pharma LLC - Form 483, 2019-02-04
February, 2020 FDA 483 Aurobindo Pharma Limited - Form 483, 2020-02-21
May, 2019 FDA 483 Church & Dwight Co., Inc. - Form 483, 2019-05-23
June, 2010 FDA 483 Rutherford Chemicals, LLC - Form 483, 2010-06-04
January, 2014 FDA 483 VILS Pharma Coating LLC - Form 483, 2014-01-27
February, 2016 EIR Amneal Pharmaceuticals LLC - EIR, 2016-02-19
April, 2017 FDA 483 InvaTech Pharma Solutions LLC - Form 483, 2017-04-04

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more